C0052451||Paraoxonases
C0033860||psoriasis
C0205160||negative
C1397014||imbalance
C0003402||anti--oxidant
C0033860||psoriasis
C0023775||lipoprotein peroxidation
C2257843||activity
C1121571||paraoxonase (PON)1
C0003402||anti-oxidant
C0003209||anti-inflammatory
C0014442||enzyme
C0003402||anti-oxidant system
C3714634||production
C0162772||reactive oxygen species
C0814995||skin cell
C0033860||psoriasis
C0052451||PON
C1335532||protein family
C1257646||PON1
C0755726||PON2
C1447656||PON3
C0011142||defense mechanisms
C0242606||oxidative stress
C2603343||study
C0017337||PON gene
C0017262||expression
C0033860||psoriasis
C0221912||cutaneous
C0242606||oxidative stress
C2603343||study
C1257890||population
C0033860||plaque psoriasis
C0013018||donors
C0677616||plastic surgery
C0191321||Skin punch biopsies
C1123023||lesional
C1123023||non lesional psoriatic skin
C0936012||analysis
C1418755||PON2
C1418756||PON3
C0017262||gene expression
C0030011||oxidation
C0005507||assays
C1123023||skin
C0029205||organ cultures
C1418755||PON2
C1418756||PON3
C0017262||gene expression
C1123023||psoriatic lesional
C1123023||non lesional skin
C0020281||H2O2
C1418755||PON2
C1418756||PON3
C0017262||expression
C1123023||skin
C0029205||organ cultures
C0003402||anti-oxidant reagent
C0001047||N-acetyl-L-cysteine
C0001047||N-acetyl-L-cysteine
C1418755||PON2
C1418756||PON3
C0017262||expression
C1123023||skin
C0029205||organ cultures
C0384648||IL-17
C0243095||findings
C2266999||pro-oxidative activity
C0003402||anti-oxidant
C0033860||psoriatic
C1123023||skin
C0086272||experimental model